410 related articles for article (PubMed ID: 37491512)
1. The potential role of the microbiota in prostate cancer pathogenesis and treatment.
Pernigoni N; Guo C; Gallagher L; Yuan W; Colucci M; Troiani M; Liu L; Maraccani L; Guccini I; Migliorini D; de Bono J; Alimonti A
Nat Rev Urol; 2023 Dec; 20(12):706-718. PubMed ID: 37491512
[TBL] [Abstract][Full Text] [Related]
2. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.
Kustrimovic N; Bombelli R; Baci D; Mortara L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675055
[TBL] [Abstract][Full Text] [Related]
4. Microbiomes in physiology: insights into 21st-century global medical challenges.
Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
[TBL] [Abstract][Full Text] [Related]
5. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota modulation: a tool for the management of colorectal cancer.
Wang Y; Li H
J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
[TBL] [Abstract][Full Text] [Related]
7. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention.
Lee SY; Lee DY; Kang JH; Kim JH; Jeong JW; Kim HW; Oh DH; Yoon SH; Hur SJ
Food Res Int; 2022 Jun; 156():111327. PubMed ID: 35651078
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Resistance and Microbiota Response.
Santacroce L; Di Domenico M; Montagnani M; Jirillo E
Curr Pharm Des; 2023; 29(5):356-364. PubMed ID: 36537602
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
10. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
11. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies.
Koning M; Herrema H; Nieuwdorp M; Meijnikman AS
Gut Microbes; 2023; 15(1):2226922. PubMed ID: 37610978
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies.
Ali A; Ara A; Kashyap MK
Mol Biol Rep; 2022 Aug; 49(8):8087-8107. PubMed ID: 35543828
[TBL] [Abstract][Full Text] [Related]
14. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
Ting NL; Lau HC; Yu J
Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
[TBL] [Abstract][Full Text] [Related]
15. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.
Huang Z; Li Y; Park H; Ho M; Bhardwaj K; Sugimura N; Lee HW; Meng H; Ebert MP; Chao K; Burgermeister E; Bhatt AP; Shetty SA; Li K; Wen W; Zuo T
Gut Microbes; 2023; 15(1):2237645. PubMed ID: 37498052
[TBL] [Abstract][Full Text] [Related]
16. Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment.
Pizzo F; Maroccia Z; Hammarberg Ferri I; Fiorentini C
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682816
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence.
Dhopatkar N; Keeler JL; Mutwalli H; Whelan K; Treasure J; Himmerich H
Psychoneuroendocrinology; 2023 Jan; 147():105959. PubMed ID: 36327759
[TBL] [Abstract][Full Text] [Related]
20. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.
Furusato B; Gao CL; Ravindranath L; Chen Y; Cullen J; McLeod DG; Dobi A; Srivastava S; Petrovics G; Sesterhenn IA
Mod Pathol; 2008 Feb; 21(2):67-75. PubMed ID: 18065961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
